Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2227
Source ID: NCT06635057
Associated Drug: Tirzepatide
Title: A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan
Acronym: T-RAM
Status: ACTIVE_NOT_RECRUITING
Study Results: NO
Results:
Conditions: Type 2 Diabetes
Interventions: DRUG: Tirzepatide
Outcome Measures: Primary: Change from Baseline in Hemoglobin A1c (HbA1c), Baseline (20 to 8 weeks Before Ramadan), Week 4-8 from Start of Ramadan (SoR) | Secondary: Percent Change from Baseline in Body Weight, Baseline (20 to 8 weeks Before Ramadan), Week 4-8 from SoR|Number of Hypoglycemic Events, Baseline (20 to 8 weeks Before Ramadan), Week 4-8 from SoR|Number of Self-Reported Gastrointestinal (GI) Adverse Events, Baseline (20 to 8 weeks Before Ramadan), Week 4-8 from SoR|Percentage of Participants Achieving HbA1c <7%, Baseline (20 to 8 weeks Before Ramadan), Week 4-8 from SoR|Change from SoR to End of Ramadan (EoR) in the 5-Level European Quality of Life 5 Dimensions (EQ-5D-5L), SoR (Week 0), EoR (Week 4)
Sponsor/Collaborators: Sponsor: Eli Lilly and Company
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 180
Study Type: INTERVENTIONAL
Study Designs: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2024-10-11
Completion Date: 2025-05
Results First Posted:
Last Update Posted: 2025-02-28
Locations: King Fahad Armed Forces, Jeddah, Al Andalus, 23311, Saudi Arabia|Al Moosa Hospital, Alahsa, Al Mubarraz, 36342, Saudi Arabia|Saudi Airlines Medical services, Jeddah, AlKhalidiyyah, Saudi Arabia|Dr Sulaiman Al Habib Medical Group-Olaya, Riyadh, Alolaya, 12214, Saudi Arabia|Dr Sulaiman Al Habib Medical Group-Alsuwaidi, Riyadh, Alsuwaidi,Riyadh, 12994-5612, Saudi Arabia|Dr Sulaiman Al Habib Medical Group-Arrayan, Riyadh, Ar Rayyan, 12214, Saudi Arabia|Dallah Hospitals, Riyadh, Nakheel, Riyadh, 12381, Saudi Arabia|King Abdulaziz Medical City-Alahsa, Alahsa, 31982, Saudi Arabia|King Abdulaziz Medical City-Jeddah, Jeddah, 21423, Saudi Arabia|King Fahad Medical City, Riyadh, 11525, Saudi Arabia|ICLDC, Abu Dhabi, United Arab Emirates|NMC Speciality Hospital, Abu Dhabi, United Arab Emirates|Rashid Center for Diabetes&Research, Ajman, United Arab Emirates|Thumbay University Hospital, Ajman, United Arab Emirates|Aster Clinics, Dubai, United Arab Emirates|Dubai Diabetes Center, Dubai, United Arab Emirates|Dubai Hospital, Dubai, United Arab Emirates|Medcare Hospital, Dubai, United Arab Emirates|Mediclinic City Hospital, Dubai, United Arab Emirates|Rashid Hospital, Dubai, United Arab Emirates
URL: https://clinicaltrials.gov/show/NCT06635057

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress